Request for Covid-19 Impact Assessment of this Report

Healthcare

North America Antivenom Market by Manufacturers, Countries, Type and Application, Forecast to 2022

  • GLO2572362
  • 118 Pages
  • April 2018
  • Healthcare
Download Sample    Get Discount   
 
Antivenom, also known as antivenin, venom antiserum and antivenom immunoglobulin, is a medication made from antibodies which is used to treat certain venomous bites and stings. They are only recommended if there is significant toxicity or a high risk of toxicity. The specific antivenom needed depends on the species involved. It is given by injection.

Scope of the Report:

This report focuses on the Antivenom in North America market, especially in United States, Canada and Mexico. This report categorizes the market based on manufacturers, countries, type and application.

Market Segment by Manufacturers, this report covers

CSL Behring

Merck & Co., Inc.

BTG Plc

Pfizer

Haffkine Bio-Pharmaceutical Corporation

Rare Disease Therapeutics

Flynn Pharma

Vins Bioproducts

Bharat Serums and Vaccines

Serum Biotech

Market Segment by Countries, covering

United States

Canada

Mexico

Market Segment by Type, covers

Polyvalent antivenom

Monovalent antivenom

Market Segment by Applications, can be divided into

Retail Pharmacies

Hospitals

Others

There are 15 Chapters to deeply display the North America Antivenom market.

Chapter 1, to describe Antivenom Introduction, product type and application, market overview, market analysis by countries, market opportunities, market risk, market driving force;

Chapter 2, to analyze the manufacturers of Antivenom, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;

Chapter 4, to show the North America market by countries, covering United States, Canada and Mexico, with sales, revenue and market share of Antivenom, for each country, from 2012 to 2017;

Chapter 5 and 6, to show the market by type and application, with sales, price, revenue, market share and growth rate by type, application, from 2012 to 2017;

Chapter 7, 8 and 9, to analyze the segment market in United States, Canada and Mexico, by manufacturers, type and application, with sales, price, revenue and market share by manufacturers, types and applications;

Chapter 10, Antivenom market forecast, by countries, type and application, with sales, price and revenue, from 2017 to 2022;

Chapter 11, to analyze the manufacturing cost, key raw materials and manufacturing process etc.

Chapter 12, to analyze the industrial chain, sourcing strategy and downstream end users (buyers);

Chapter 13, to describe sales channel, distributors, traders, dealers etc.

Chapter 14 and 15, to describe Antivenom Research Findings and Conclusion, Appendix, methodology and data source

Table of Contents

1 Market Overview

1.1 Antivenom Introduction

1.2 Market Analysis by Type

1.2.1 Polyvalent antivenom

1.2.2 Monovalent antivenom

1.3 Market Analysis by Applications

1.3.1 Retail Pharmacies

1.3.2 Hospitals

1.3.3 Others

1.4 Market Analysis by Countries

1.4.1 United States Status and Prospect (2012-2022)

1.4.2 Mexico Status and Prospect (2012-2022)

1.4.3 Canada Status and Prospect (2012-2022)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 CSL Behring

2.1.1 Profile

2.1.2 Antivenom Type and Applications

2.1.2.1 Type 1

2.1.2.2 Type 2

2.1.3 CSL Behring Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.1.4 Business Overview

2.1.5 CSL Behring News

2.2 Merck & Co., Inc.

2.2.1 Profile

2.2.2 Antivenom Type and Applications

2.2.2.1 Type 1

2.2.2.2 Type 2

2.2.3 Merck & Co., Inc. Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.2.4 Business Overview

2.2.5 Merck & Co., Inc. News

2.3 BTG Plc

2.3.1 Profile

2.3.2 Antivenom Type and Applications

2.3.2.1 Type 1

2.3.2.2 Type 2

2.3.3 BTG Plc Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.3.4 Business Overview

2.3.5 BTG Plc News

2.4 Pfizer

2.4.1 Profile

2.4.2 Antivenom Type and Applications

2.4.2.1 Type 1

2.4.2.2 Type 2

2.4.3 Pfizer Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.4.4 Business Overview

2.4.5 Pfizer News

2.5 Haffkine Bio-Pharmaceutical Corporation

2.5.1 Profile

2.5.2 Antivenom Type and Applications

2.5.2.1 Type 1

2.5.2.2 Type 2

2.5.3 Haffkine Bio-Pharmaceutical Corporation Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.5.4 Business Overview

2.5.5 Haffkine Bio-Pharmaceutical Corporation News

2.6 Rare Disease Therapeutics

2.6.1 Profile

2.6.2 Antivenom Type and Applications

2.6.2.1 Type 1

2.6.2.2 Type 2

2.6.3 Rare Disease Therapeutics Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.6.4 Business Overview

2.6.5 Rare Disease Therapeutics News

2.7 Flynn Pharma

2.7.1 Profile

2.7.2 Antivenom Type and Applications

2.7.2.1 Type 1

2.7.2.2 Type 2

2.7.3 Flynn Pharma Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.7.4 Business Overview

2.7.5 Flynn Pharma News

2.8 Vins Bioproducts

2.8.1 Profile

2.8.2 Antivenom Type and Applications

2.8.2.1 Type 1

2.8.2.2 Type 2

2.8.3 Vins Bioproducts Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.8.4 Business Overview

2.8.5 Vins Bioproducts News

2.9 Bharat Serums and Vaccines

2.9.1 Profile

2.9.2 Antivenom Type and Applications

2.9.2.1 Type 1

2.9.2.2 Type 2

2.9.3 Bharat Serums and Vaccines Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.9.4 Business Overview

2.9.5 Bharat Serums and Vaccines News

2.10 Serum Biotech

2.10.1 Profile

2.10.2 Antivenom Type and Applications

2.10.2.1 Type 1

2.10.2.2 Type 2

2.10.3 Serum Biotech Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.10.4 Business Overview

2.10.5 Serum Biotech News

3 North America Antivenom Market Competition, by Manufacturer

3.1 North America Antivenom Sales and Market Share by Manufacturer (2016-2017)

3.2 North America Antivenom Revenue and Market Share by Manufacturer (2016-2017)

3.3 North America Antivenom Price by Manufacturers (2016-2017)

3.4 Market Concentration Rate

3.4.1 Top 3 Antivenom Manufacturer Market Share

3.4.2 Top 5 Antivenom Manufacturer Market Share

3.5 Market Competition Trend

4 North America Antivenom Market Analysis by Countries

4.1 North America Antivenom Sales Market Share by Countries

4.2 North America Antivenom Sales by Countries (2012-2017)

4.3 North America Antivenom Revenue (Value) by Countries (2012-2017)

5 North America Market Segmentation Antivenom by Type

5.1 North America Antivenom Sales, Revenue and Market Share by Type (2012-2017)

5.1.1 North America Antivenom Sales and Market Share by Type (2012-2017)

5.1.2 North America Antivenom Revenue and Market Share by Type (2012-2017)

5.2 Polyvalent antivenom Sales Growth and Price

5.2.1 North America Polyvalent antivenom Sales Growth (2012-2017)

5.2.2 North America Polyvalent antivenom Price (2012-2017)

5.3 Monovalent antivenom Sales Growth and Price

5.3.1 North America Monovalent antivenom Sales Growth (2012-2017)

5.3.2 North America Monovalent antivenom Price (2012-2017)

6 North America Market Segmentation Antivenom by Application

6.1 North America Antivenom Sales Market Share by Application (2012-2017)

6.2 Retail Pharmacies Sales Growth (2012-2017)

6.3 Hospitals Sales Growth (2012-2017)

6.4 Others Sales Growth (2012-2017)

7 United States Antivenom Sales, Revenue, by Type, Application and Manufacturers

7.1 United States Antivenom Revenue, Sales and Growth Rate (2012-2017)

7.2 United States Antivenom Sales and Market Share by Type

7.3 United States Antivenom Sales by Application (2012-2017)

7.4 United States Antivenom Sales, Revenue and Market Share by Manufacturer

7.4.1 United States Antivenom Sales and Market Share by Manufacturer

7.4.2 United States Antivenom Revenue and Market Share by Manufacturer

7.5 United States Antivenom Export and Import (2012-2017)

8 Canada Antivenom Sales, Revenue, by Type, Application and Manufacturers

8.1 Canada Antivenom Revenue, Sales and Growth Rate (2012-2017)

8.2 Canada Antivenom Sales and Market Share by Type

8.3 Canada Antivenom Sales by Application (2012-2017)

8.4 Canada Antivenom Sales, Revenue and Market Share by Manufacturer

8.4.1 Canada Antivenom Sales and Market Share by Manufacturer

8.4.2 Canada Antivenom Revenue and Market Share by Manufacturer

8.5 Canada Antivenom Export and Import (2012-2017)

9 Mexico Antivenom Sales, Revenue, by Type, Application and Manufacturers

9.1 Mexico Antivenom Revenue, Sales and Growth Rate (2012-2017)

9.2 Mexico Antivenom Sales and Market Share by Type

9.3 Mexico Antivenom Sales by Application (2012-2017)

9.4 Mexico Antivenom Sales, Revenue and Market Share by Manufacturer

9.4.1 Mexico Antivenom Sales and Market Share by Manufacturer

9.4.2 Mexico Antivenom Revenue and Market Share by Manufacturer

9.5 Mexico Antivenom Export and Import (2012-2017)

10 Antivenom Market Forecast (2017-2022)

10.1 North America Antivenom Sales, Revenue and Growth Rate (2017-2022)

10.2 Antivenom Market Forecast by Countries (2017-2022)

10.2.1 United States Antivenom Forecast (2017-2022)

10.2.2 Canada Antivenom Forecast (2017-2022)

10.2.3 Mexico Antivenom Forecast (2017-2022)

10.3 Antivenom Market Forecast by Type (2017-2022)

10.4 Antivenom Market Forecast by Application (2017-2022)

11 Antivenom Manufacturing Cost Analysis

11.1 Antivenom Key Raw Materials Analysis

11.1.1 Key Raw Materials

11.1.2 Price Trend of Key Raw Materials

11.1.3 Key Suppliers of Raw Materials

11.1.4 Market Concentration Rate of Raw Materials

11.2 Proportion of Manufacturing Cost Structure

11.2.1 Raw Materials

11.2.2 Labor Cost

11.2.3 Manufacturing Expenses

11.3 Manufacturing Process Analysis of Antivenom

12 Industrial Chain, Sourcing Strategy and Downstream Buyers

12.1 Antivenom Industrial Chain Analysis

12.2 Upstream Raw Materials Sourcing

12.3 Raw Materials Sources of Antivenom Major Manufacturers in 2016

12.4 Downstream Buyers

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Analyst Introduction

15.3 Data Source

List of Tables and Figures

Figure Antivenom Picture

Table Product Specifications of Antivenom

Figure North America Sales Market Share of Antivenom by Types in 2016

Table Types of Antivenom

Figure Polyvalent antivenom Picture

Table Major Manufacturers of Polyvalent antivenom

Figure Monovalent antivenom Picture

Table Major Manufacturers of Monovalent antivenom

Table North America Antivenom Sales Market Share by Applications in 2016

Table Applications of Antivenom

Figure Retail Pharmacies Picture

Figure Hospitals Picture

Figure Others Picture

Figure United States Antivenom Revenue (Million USD) and Growth Rate (2012-2022)

Figure Mexico Antivenom Revenue (Million USD) and Growth Rate (2012-2022)

Figure Canada Antivenom Revenue (Million USD) and Growth Rate (2012-2022)

Table CSL Behring Basic Information, Manufacturing Base and Competitors

Table CSL Behring Antivenom Type and Applications

Table CSL Behring Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Merck & Co., Inc. Basic Information, Manufacturing Base and Competitors

Table Merck & Co., Inc. Antivenom Type and Applications

Table Merck & Co., Inc. Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table BTG Plc Basic Information, Manufacturing Base and Competitors

Table BTG Plc Antivenom Type and Applications

Table BTG Plc Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Pfizer Basic Information, Manufacturing Base and Competitors

Table Pfizer Antivenom Type and Applications

Table Pfizer Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Haffkine Bio-Pharmaceutical Corporation Basic Information, Manufacturing Base and Competitors

Table Haffkine Bio-Pharmaceutical Corporation Antivenom Type and Applications

Table Haffkine Bio-Pharmaceutical Corporation Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Rare Disease Therapeutics Basic Information, Manufacturing Base and Competitors

Table Rare Disease Therapeutics Antivenom Type and Applications

Table Rare Disease Therapeutics Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Flynn Pharma Basic Information, Manufacturing Base and Competitors

Table Flynn Pharma Antivenom Type and Applications

Table Flynn Pharma Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Vins Bioproducts Basic Information, Manufacturing Base and Competitors

Table Vins Bioproducts Antivenom Type and Applications

Table Vins Bioproducts Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Bharat Serums and Vaccines Basic Information, Manufacturing Base and Competitors

Table Bharat Serums and Vaccines Antivenom Type and Applications

Table Bharat Serums and Vaccines Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Serum Biotech Basic Information, Manufacturing Base and Competitors

Table Serum Biotech Antivenom Type and Applications

Table Serum Biotech Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table North America Antivenom Sales by Manufacturer (2016-2017)

Figure North America Antivenom Sales Market Share by Manufacturer in 2016

Figure North America Antivenom Sales Market Share by Manufacturer in 2017

Table North America Antivenom Revenue by Manufacturer (2016-2017)

Figure North America Antivenom Revenue Market Share by Manufacturer in 2016

Figure North America Antivenom Revenue Market Share by Manufacturer in 2017

Table North America Antivenom Price by Manufacturers (2016-2017)

Figure Top 3 Antivenom Manufacturer Market Share in 2016

Figure Top 3 Antivenom Manufacturer Market Share in 2017

Figure Top 5 Antivenom Manufacturer Market Share in 2016

Figure Top 5 Antivenom Manufacturer Market Share in 2017

Figure North America Antivenom Sales and Growth (2012-2017)

Table North America Antivenom Sales by Countries (2012-2017)

Table North America Antivenom Sales Market Share by Countries (2012-2017)

Figure North America 2012 Antivenom Sales Market Share by Countries

Figure North America 2016 Antivenom Sales Market Share by Countries

Figure North America Antivenom Revenue and Growth (2012-2017)

Table North America Antivenom Revenue by Countries (2012-2017)

Table North America Antivenom Revenue Market Share by Countries (2012-2017)

Table North America 2012 Antivenom Revenue Market Share by Countries

Table North America 2016 Antivenom Revenue Market Share by Countries

Table North America Antivenom Sales by Type (2012-2017)

Table North America Antivenom Sales Share by Type (2012-2017)

Table North America Antivenom Revenue by Type (2012-2017)

Table North America Antivenom Revenue Share by Type (2012-2017)

Figure North America Polyvalent antivenom Sales Growth (2012-2017)

Figure North America Polyvalent antivenom Price (2012-2017)

Figure North America Monovalent antivenom Sales Growth (2012-2017)

Figure North America Monovalent antivenom Price (2012-2017)

Table North America Antivenom Sales by Application (2012-2017)

Table North America Antivenom Sales Share by Application (2012-2017)

Figure North America Retail Pharmacies Sales Growth (2012-2017)

Figure North America Hospitals Sales Growth (2012-2017)

Figure North America Others Sales Growth (2012-2017)

Figure United States Antivenom Revenue and Growth (2012-2017)

Figure United States Antivenom Sales and Growth (2012-2017)

Table United States Antivenom Sales by Type (2012-2017)

Table United States Antivenom Sales Market Share by Type (2012-2017)

Table United States Antivenom Sales by Application (2012-2017)

Table United States Antivenom Sales Market Share by Application (2012-2017)

Table United States Antivenom Sales by Manufacturer (2016-2017)

Figure United States Antivenom Sales Market Share by Manufacturer in 2016

Figure United States Antivenom Sales Market Share by Manufacturer in 2017

Table United States Antivenom Revenue by Manufacturer (2016-2017)

Figure United States Antivenom Revenue Market Share by Manufacturer in 2016

Figure United States Antivenom Revenue Market Share by Manufacturer in 2017

Table United States Antivenom Export and Import (2012-2017)

Figure Canada Antivenom Revenue and Growth (2012-2017)

Figure Canada Antivenom Sales and Growth (2012-2017)

Table Canada Antivenom Sales by Type (2012-2017)

Table Canada Antivenom Sales Market Share by Type (2012-2017)

Table Canada Antivenom Sales by Application (2012-2017)

Table Canada Antivenom Sales Market Share by Application (2012-2017)

Table Canada Antivenom Sales by Manufacturer (2016-2017)

Figure Canada Antivenom Sales Market Share by Manufacturer in 2016

Figure Canada Antivenom Sales Market Share by Manufacturer in 2017

Table Canada Antivenom Revenue by Manufacturer (2016-2017)

Figure Canada Antivenom Revenue Market Share by Manufacturer in 2016

Figure Canada Antivenom Revenue Market Share by Manufacturer in 2017

Table Canada Antivenom Export and Import (2012-2017)

Figure Mexico Antivenom Revenue and Growth (2012-2017)

Figure Mexico Antivenom Sales and Growth (2012-2017)

Table Mexico Antivenom Sales by Type (2012-2017)

Table Mexico Antivenom Sales Market Share by Type (2012-2017)

Table Mexico Antivenom Sales by Application (2012-2017)

Table Mexico Antivenom Sales Market Share by Application (2012-2017)

Table Mexico Antivenom Sales by Manufacturer (2016-2017)

Figure Mexico Antivenom Sales Market Share by Manufacturer in 2016

Figure Mexico Antivenom Sales Market Share by Manufacturer in 2017

Table Mexico Antivenom Revenue by Manufacturer (2016-2017)

Figure Mexico Antivenom Revenue Market Share by Manufacturer in 2016

Figure Mexico Antivenom Revenue Market Share by Manufacturer in 2017

Table Mexico Antivenom Export and Import (2012-2017)

Figure North America Antivenom Sales, Revenue and Growth Rate (2017-2022)

Table North America Antivenom Sales Forecast by Countries (2017-2022)

Table North America Antivenom Market Share Forecast by Countries (2017-2022)

Figure United States Antivenom Sales Forecast (2017-2022)

Figure Canada Antivenom Sales Forecast (2017-2022)

Figure Mexico Antivenom Sales Forecast (2017-2022)

Table North America Antivenom Sales Forecast by Type (2017-2022)

Table North America Antivenom Market Share Forecast by Type (2017-2022)

Table North America Antivenom Sales Forecast by Application (2017-2022)

Table North America Antivenom Market Share Forecast by Application (2017-2022)

Table Sales Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Antivenom

Figure Manufacturing Process Analysis of Antivenom

Figure Antivenom Industrial Chain Analysis

Table Raw Materials Sources of Antivenom Major Manufacturers in 2016

Table Major Buyers of Antivenom

Table Distributors/Traders/ Dealers List

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

Regenerative Medicine Market by Product Type (Cell Therapy, Gene Therapy, Tissue Engineering, and Small Molecule & Biologic), Material (Synthetic Material, Biologically Derived Material, Genetically Engineered Material, and Pharmaceutical), and Application (Cardiovascular, Oncology, Dermatology, Musculoskeletal, Wound Healing, Ophthalmology, Neurology, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

The global regenerative medicine market was valued at $5,444 million in 2016, and is estimated to reach $39,325 million by 2023, registering a CAGR of 32.2% from 2017 to 2023. Regenerative medicines are used to repair, replace, and regenerate tissues & organs that are affected owin...

  • Publish Date: May 29, 2018
  • $5370
World Medical Robotics and Computer - Assisted Surgery Market - Opportunities and Forecasts, 2015 - 2022

The medical robotics and computer-assisted surgery is a combination of equipment, accessories, software, and services that aid in performing different functions, such as robotic minimally invasive and non-invasive radiosurgeries, rehabilitation therapies, and hospital & pharmacy automation. Surgical robotics...

  • Publish Date: May 1, 2016
  • $5370